Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
The Ted Rogers Centre for Heart Research is thrilled to welcome Dr. Cedric Manlhiot as the inaugural Rogers Innovator of Cardiovascular Precision Medicine at SickKids. In addition to his role at TRCHR, Dr. Manlhiot will be a Scientist in the Translational Medicine...
Entrepreneurship for Cardiovascular Health Opportunities (ECHO) is a 12-month national training program supporting cardiovascular research commercialization through education, mentorship, networking, and funding. Led by a diverse team of experts, ECHO fosters...
Launching in March 2024, emergency department (ED) physicians at the University Health Network (UHN) can now access the Emergency Heart Failure Mortality Risk Grade (EHMRG) calculator within Epic, UHN’s electronic medical record. The EHMRG score estimates the risk of...
Cardiomyopathy is a leading cause of heart failure in children, and there are currently no effective treatments. Could emerging therapies that successfully target the root cause of the condition in adults also work well in children? That was the question Dr....
Please join us for an ECHO webinar on Tuesday May 25, 2021 (11 am – 12 pm) featuring Dr. Misti Ushio (CEO, TARA Biosystems). Dr. Ushio’s presentation entitled, “TARA Biosystems: our journey of engineering human biology to transform cardiac drug discovery”, will feature an overview of TARA Biosystems, its technologies and the story behind its success.
TARA Biosystems harnesses innovations in stem cell biology and tissue engineering to generate in vitro biology that recapitulates human physiology with unprecedented fidelity. Their platform captures integrated physiologic endpoints of human cardiac function across a wide repertoire of cardiac disease phenotypes. Their data facilitates decisive evaluation of the efficacy and risk of novel medicines, increasing the probability of success and decreasing the long timeframes typically associated with drug discovery efforts.
Register in advance for this meeting: https://us02web.zoom.us/meeting/register/tZ0scO-pqT8oEtBOllvBH-I5YK87lqTB1fd8
After registering, you will receive a confirmation email containing information about joining the webinar.
ECHO is an entrepreneurship training program, funded and organized in a partnership between (i) the Translational Biology and Engineering Program (TBEP), the University of Toronto component of the Ted Rogers Centre for Heart Research, and (ii) the Health Innovation Hub (H2i).
